Indigenous Australians generally have a poor health status and an elevated cancer mortality that has increased in recent decades. A cohort of 2,273 Aboriginal and Torres Strait Islander (TSI) adults (181 years) from 26 remote communities in far North Queensland, who were initially free of cancer, were followed-up for an average of 15 years. The associations of baseline anthropometric, biochemical and behavioural factors with cancer incidence were investigated using competing risk survival analysis. The age-standardised incidence (all cancers) was 5.2 cases/1,000 person-years (pys) (95% CI 4.1-6.6). Liver/bile duct and lung were the most common cancer sites. Overall cancer incidence was significantly higher in TSIs than Aboriginal people. The baseline prevalence of diabetes was 15.6% in Aboriginal and 25.6% in TSI people. The smoking rate of 59.8% for Aboriginal people was higher than the rate of 45.2% for TSIs. At follow-up, the adjusted sub hazard ratios (SHRs) of diabetes for all cancers combined were 1.8 (95% CI, 1.3-2.6), and for digestive system cancers, 2.3 (95% CI, 1.2-4.4). Smokers had a 60% higher risk (SHR 1.6, 95% CI: 1.1-2.0) for all cancers combined and a fourfold risk (SHR 3.7, 95% CI 1.7-8.0) for lung cancers when compared to non-smokers, regardless of age, sex and ethnicity. The most common cancers encountered by this Indigenous cohort and their consequences are potentially preventable in Indigenous Australians by effective management of highly prevalent modifiable risks in primary service settings, screening participation and arranging for good access to treatment services.
Introduction
Epidemiologic evidence indicates that diabetes is associated with an increased risk of cancer for all sites combined, and for specific cancer sites, and plausible explanatory pathophysiological mechanisms have been proposed. [1] [2] [3] [4] [5] [6] The prevalence of diabetes has tripled in the past three decades in Australian adults and is now estimated to be about 6%, but Indigenous Australians were found to have a four-times higher prevalence than non-Indigenous Australians in 2013-2014. 7 Cancer survival at the national level has increased from 48% in 1984-88 to 68% in 2009-13 for all cancers combined. 8 Nonetheless cancer remains the leading cause of premature death for the Australian population. 9 Meanwhile Indigenous disparities in Australia have persisted or widened, such that Aboriginal and Torres Strait Island people (TSIs) (referred in this report as Indigenous people) now have about the double the risk of lung cancer and four times the risk of liver cancer as non-Indigenous Australians. 10 Leading cancers in Indigenous people reflect a higher prevalence of risk factors such as smoking, alcohol consumption, cancer-causing infections and a lower participation in cancer screening. [11] [12] [13] [14] National databases have demonstrated their value in showing these associations, enabling broad cross-country and regional comparisons, and investigation of time trends, but generally they lack the detail to accurately quantify risk-factor effects, both individually and in combination. This applies in particular for sub-groups of Indigenous people where numbers are small and with widely distributed geographically.
Our study reports on a cohort of 2,273 Indigenous adults from rural and remote North Queensland. We have found a fourfold incidence of diabetes in this cohort compared to Australians in general, which was related to obesity and a number of metabolic risk factors, such as albuminuria and Gamma-glutamyl transferase (GGT). 15, 16 Cancers, together with coronary heart diseases (CHD), were the leading causes of death in this cohort during a 6-year follow-up period. 16 We have reported the association of diabetes, other metabolic risks, and smoking with CHD and related deaths in this Indigenous cohort. 17, 18 In our study, we explore the associations of diabetes, metabolic risks and smoking with all cancers combined and with the most common cancer sites, and the differences in these associations between Aboriginal and TSI people.
Methods

Study population
Baseline data were collected for participants from 26 rural communities in Far North Queensland (the northernmost part of the state of Queensland, Australia) who had joined in a community wellness screening project called the "Well Person's Health Check" (WPHC) since 1998. Study methods have been reported in detail elsewhere. 19 In brief, all Indigenous residents aged 13 years and over were invited to attend a health check. Based on the local census data, the study achieved a participation rate of 45% with a higher participation occurring in the smaller communities. 9 In general, participants were not demographically different from the Australian Indigenous population overall. 19 Written informed consent was obtained from each participant. Study protocols were approved by the Cairns Base Hospital Human Research Ethics Committee and support given for the study by peak Indigenous Health Organizations, Apunipima Cape York Health Council and the Torres Strait and Northern Peninsula Area Health Council.
Baseline measurements
Participants were assessed anthropometrically in light clothing and weighed to the nearest 0.1 kg. Height and waist circumference (WC) were recorded to the nearest centimetre with the latter measured by a single technician at the level of the umbilicus. Blood pressure (BP) was calculated as the mean of three measurements using a Dinamap model 800 automated blood pressure monitor, measured while seated after a 10 min rest (Critikon, Tampa, FL). Tobacco and alcohol consumption were assessed using the same methodology as for the National Nutrition Survey 1995 and categorised according to the Australian dietary guidelines. 20 Physical activity (PA) was measured using a 7-day recall method and categorised according to WHO criteria in which "enough" meant doing moderate to vigorous physical activity for >30 min/day for 5 days in the week before the survey. Alcohol drinkers were defined as those who had consumed any alcoholic drinks in the 7 days immediately preceding the survey. GGT, glucose, total cholesterol, high density lipoprotein cholesterol (HDL) and triglyceride levels were measured in fasting blood collected in the early morning by a medical officer, registered nurse or trained phlebotomist. 19 GGT was measured using the kinetic photometric procedure with Cobas Integra 800 (Roche Diagnostics, www.roche-diagnostics). Elevated GGT was defined as GGT 50 IU, with a GGT <50 IU as normal. These criteria were set by the Queensland Pathology Service, the main provider of public sector pathology services in Queensland (http://www.health. qld.gov.au/qhcss/qhps/default.asp). Blood glucose and blood lipids were measured using photometric enzyme endpoint assays with Cobas Integra 700/400 (Roche Diagnostics, www.roche-diagnostics). Urine specimens were provided by participants in sterile 50 ml containers from the first morning void. Samples were tested using a dipstick urinalysis (Combur-test, Roche Diagnostics, www.rochediagnostics) for protein, pH, nitrites, leucocytes and blood. The urine albumin creatinine ratio (UACR) was measured by immunoassay in mg/mmol and microalbuminuria was defined as UACR 2.5 mg/mmol for males and 3.5 mg/ mmol for females. 21 All pathology testing was undertaken at the Cairns Base hospital. 
Record matching and outcome determination
Participants' baseline data were linked to hospitalisation and deaths-record data available through the Queensland Hospital What's new? This is the first formal report of cancer incidence and associated biochemical and lifestyle risk factors in a 15-year follow-up of Indigenous Australians in remote North Queensland communities. Diabetes, and smoking, which are prevalent in the Indigenous communities, have been associated with cancer incidence. A four-fold incidence of diabetes was found in this cohort compared with the general population, which was related to obesity and several metabolic risk factors. The most commonly encountered cancers and their consequences are potentially preventable in Indigenous Australians through effective management of highly prevalent modifiable risks, greater screening participation, and better access to treatment services.
Admitted Patient Data Collection dataset from the screening date to the end of 2015, using deterministic linkage where feasible, or otherwise probabilistic linkage, followed by manual clerical review. The linkage was conducted by the Statistical Analysis and Linkage team from Queensland Health in 2016. Hospitalisation data were available that included patient's age, sex, ethnicity and for episodes of admission, admission and discharge dates in month and year.
Cancer events were those coded using International Classification of Disease (ICD) diagnosis codes (versions 9 & 10) for hospitalisations in the "C00-C96" and "D45, D465 D469" range for malignant neoplasms, as employed by Cancer Australia (Supporting Information Table S1 ). 10 Death records were classified according to whether "any cancer" was recorded as a death cause. Cancers were grouped by type as skin, head and neck, digestive, respiratory, breast, gynaecological, urinary tract, urogenital, endocrinal, lymphohaematopoietic or cancer of unknown primary, as employed by the Australasian Association of Cancer Registries. 10 This classification was designed to obtain sufficient numbers of cases for analysis (i.e., to have 30 cases per cancer group).
The start date of follow-up was the screening date of the WPCH and the censoring date was the date of diagnosis of the first cancer or death from any cause, whichever came first. If neither an admission nor a death occurred during the followup period, the censoring date was December 15th, 2015.
Statistical analysis
A total of 2,273 consenting Indigenous adults were included in the study (excluding those who had been hospitalised for cancer before the WPCH screening date).
Baseline characteristics, including demographic, anthropometric, biochemical and lifestyle characteristics, were compared by ethnicity using ANOVA for continuous measures and Pearson's v 2 test for categorical variables. Age-specific person-year incidence rates, stratified by ethnicity, were calculated by dividing numbers of new cases by total numbers of follow-up person years (pys) for the corresponding subgroups. Direct standardisation was undertaken using 2001 Australian Bureau of Statistics national census data as the reference population. 10 The cumulative incidence of cancer over a mean follow-up period of 15 years was calculated using the Kaplan-Meier method for a range of population strata, including strata classified at baseline by BMI, WC category, fasting glucose quartile, presence or absence of diabetes, hypertension, fasting triglyceride, GGT, and UACR, smoking status, alcohol consumption, and physical activity. The incidence rates for these population strata were compared using the log-rank test.
The associations of biomedical and behavioural risk factors with cancer risk were assessed using sub-hazard ratios (SHR) obtained from competing-risk survival analysis to consider other exclusive events such as death or cancers occurring during the follow up period as competing risks. 22 Proportional hazards assumptions were tested using Schoenfeld residuals and graphic assessment. The association was adjusted for age and sex within each Indigenous group (i.e., Aboriginal or TSI). Further adjustment was made for ethnicity when analysing SHRs for the collective cohort. Ethnic differences of associations of risk factors with cancer incidence were investigated by stratified analyses and tested using interaction terms where both ethnicity groups were combined in the Cox model.
Statistical analyses investigated predictors of all cancers collectively and of cancers of the digestive system (oesophagus, stomach, intestine, liver and bile duct, gall-bladder and pancreas) and respiratory system (lung, mediastinum and pleura), and all other cancers combined. For all cancers combined, the competing risks were deaths from non-cancer causes; for cancers of the digestive system, the competing risks were deaths or cancers of primary sites other than the digestive system; for cancers of the respiratory system, the competing risks were deaths or cancers of primary sites other than the respiratory tract and for other cancers combined, the competing risks were non-cancer deaths or digestive or respiratory system cancers. "stcrreg" was used to fit the proportional subhazard models.
All statistical analyses were performed using STATA version 13.1(StataCorp LP, College Station, TX). Statistical significance was assumed when p < 0.05.
Results
Study cohort characteristics and cancer incidence
Of the 2,273 Indigenous adults (mean age 42.8 years), 1,317 (58%) were Aboriginal, 811 (36%) were TSI people, and 145 (6%) had both Aboriginal and TSI ethnicity. Baseline health status differed significantly between the two groups. Specifically, the TSIs had higher BMI, WC, BP and fasting plasma glucose, but lower levels of triglycerides and GGT, lower selfreported prevalence of smoking and alcohol consumption. The overall prevalence of overweight and obesity (BMI 25 kg/m 2 ) was 68%; 41% had hypertension and 19% had been diagnosed with diabetes. More than half (55%) and two-thirds (67%) were self-reported smokers and alcohol drinkers, respectively. Only about a quarter (26%) met PA recommendation levels (Table 1) .
A total of 151 cancer cases were detected through hospital and/or death records for a mean follow-up of 15 years (median 16 years). They comprised 71 TSIs, 70 Aboriginal and 10 cases who had both ethnicities ( Table 2 ). The most commonly reported cancers were classified as lung (36 cases) and liver (17 cases) cancers in the clinical groupings of respiratory system (39 cases) and digestive system (40 cases), respectively. Other cancers included gynaecological (14 cases), lymphohaematopoietic (12 cases), breast (9 cases), urogenital (9 cases) and other cancers (28 cases) (Supporting Information Table S1 ).
The overall crude incidence rate was 4.6 cases/1,000 person-years (pys) (95% CI 3.9-5.3 cases/1,000 pys) and the age-standardised rate (2001 Australia census population) was Abdominal obesity classified as WC 102 cm for males and 88 cm for females using WHO WC sex-specific criteria; hypertension defined as BP >140/ 90 mm Hg, or an established hypertension diagnosis in clinic files; diabetes as either clinical diagnosis verified by the participants' medical records or a 2 hr glucose tolerance test, or fasting blood glucose level 57.0 mmol/L; albuminuria as urine albumin: creatinine ratio 2.5 mg/mmol for makes and 3.5 mg/mmol for females; PA sufficient as having moderate to vigorous physical activity 30 min/day for 5 days in the week before the survey. Abbreviations: WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; GGT: Gamma-glutamyl transferase; PA: physical activity.
5.2 cases/1,000 pys (95% CI 4.4-6.6 cases/1,000 pys). The incidence was similar in men and women for both Aboriginal and TSI people. TSIs had a significantly higher all-cancer age-standardised rate (7.8, 95% CI 5.6-10.8 cases/1,000 pys) than Aboriginal people (3.8, 95% CI 2.7-5.4 cases/1,000 pys), and a higher incidence for cancers of the digestive system (2.5 cases/1,000 pys with 95% CI 1.4-4.4 in TSIs vs. 0.8 cases/1,000 pys with 95% CI 0.3-1.7 in Aboriginal people). The incidence of cancers of the respiratory system or other cancer sites combined was not significantly different by ethnicity. Older adults (45 years) had an incidence of 9.0 cases/1,000 pys (95% CI 7.5-10.9) compared to the rate of 2.0 cases/1,000 pys (95% CI 1.5-2.7) for younger adults for all cancers collectively, and a similar age gradient was suggested for other cancer sites in both ethnic groups.
Biomedical and behavioural factors and cancer incidence
There was not an overall difference in incidence, either in Aboriginal or TSI people, by baseline BMI, WC, or hypertension, blood lipids, GGT, albuminuria, or PA. The crude incidence was lower in alcohol drinkers (4.3 with 95% CI 3.0-6.2 cases/1,000 pys) compared to non-drinkers (9.2, 95% CI: 6.8-12.5 cases/1,000pys) in TSIs but the difference was not significant when age was adjusted. Adults with blood glucose 5.7 mmol/L had a higher incidence rate (7.1, 95% CI 5.5-9.0 cases/1,000 pys) compared to 3.6 cases/1,000 pys (95% CI 2.9-4.4) for glucose level <5.7 mmol/L (Supporting Information Table S2 ).
Among all Indigenous adults, baseline diabetes was associated with 80% increased risk of cancer incidence (SHR 1.8, 95% CI 1.3-2.6). The adjusted risk of cancer of the digestive system was stronger for those with diabetes (SHR 2.3, 95% CI 1.2-4.4), but an elevation in risk was not found with diabetes for respiratory cancer (SHR 1.2, 95% CI 0.6-2.6) or other cancers (SHR 1.6, 95% CI 1.0-2.8). Smokers had a significantly higher risk (SHR 1.6, 95% CI 1.1-2.0) compared to non-smokers of cancer overall, but not for cancer of the digestive system (SHR 0.9, 95% CI 0.5-1.6) or other cancers (SHR 1.3, 95% CI 0.8-2.0). The risk of lung cancer in smokers compared to non-smokers was high (SHR 3.7, 95% CI 1.7-8.0) after adjusting for age, sex and ethnicity (Table 3 ). The effect size of diabetes or smoking on overall cancer did not vary by age or sex. There was no interaction between diabetes and smoking in their associations with overall cancer or cancer types.
The effect of diabetes and smoking on cancer incidence varied with ethnicity as indicated in the stratified results (Table 3) . Notably, diabetes appeared to be a more pronounced risk factor for cancers of the digestive system in TSIs (SHR 3.2, 95% CI 1.4-7.4) than in Aboriginal adults (SHR 1.2, 95% CI 0.3-4.5), although this difference was not statistically significant (SHR of interaction term 2.5, 95% CI 0.6-11.6). The association of smoking with overall cancer was higher in Aboriginal (SHR 2.3, 9% CI 1.3-4.0) than in TSI people (SHR 0.9, 95% CI 0.6-1.5) with a SHR of 2.6 for Table 2 . SHR: sub distribution hazard ratio from competing risk survival analysis; death other than cancers as competing risk for all cancers; death or cancers other than digestive cancers for digestive cancers; death or cancers other than respiratory cancers for respiratory cancers; death other than digestive or respiratory cancers for other cancers combined. 
Discussion
This is the first cohort study reporting comparative cancer incidence in Australia's two principal Indigenous populations, using linked inpatient records. The age-standardised all-cancer incidence was 5.2 cases/1,000 pys, which was marginally higher than the corresponding incidence published for the national Indigenous population of 4.6/1,000 population in 2004-2008 10 and projected for the overall population in 2017 of around 5.0/1,000 pys. 8 The Indigenous cancer burden is a great challenge for the Australian health system, which has done well in reducing cancer mortality across the population more generally. 8, 23, 24 The leading cancers in the national Indigenous population are cancers of the lung, breast, colon/rectum, prostate and unknown primary site. 10 Similarly, lung cancer is generally the most common cancer type reported in other Indigenous populations in developed counties. 25 However, the common cancer incidence sites in the present Indigenous cohort differed from the common sites in non-Indigenous Australians where lead sites have been cancers of the breast, colon/rectum, prostate and skin (melanoma). 8 In addition, liver cancer and lymphohaematopoietic cancer were more common in the Indigenous cohort than seen for Australians overall. 8 We found that cancer incidence was higher in TSIs than Aboriginal people, with cancers of the digestive system contributing to this difference. Differences in cancer profiles between these groups highlight the need for a customised mix of preventive strategies by ethnicity.
Indigenous adults with diabetes were 80% more likely than those without diabetes to develop cancer, with much stronger associations with diabetes presenting for the digestive cancers (twofold), mostly due to associations of diabetes with liver and colorectal cancers. The risks of digestive cancers associated with diabetes may be related to insulin exposure to these sensitive sites 3, 5 or metabolic dysfunction involved in the association. 4, 26 Added to our previous investigations, [15] [16] [17] [18] our study links diabetes to increased cancer incidence and the excess premature death in this population. Diabetes, which is highly prevalent in the Indigenous Australian population, can be prevented by controlling risk factors such as overweight and obesity, poor diet and sedentary lifestyles. 27 The adverse effects of diabetes can also be controlled, as for example by improving health service delivery. 28 Further gains may be possible by addressing cultural and infrastructural barriers in primary health settings. 26, 29 Diabetes prevalence can be used as a marker for targeting cancer screening and medical surveillance in these high-risk populations. They would complement the successful national cancer screening programmes. 8 Smoking was confirmed in this population as a strong risk for cancer, as shown elsewhere. 30, 31 Australia has been cited among the highest achieving countries for reducing smoking rates through health-related policy initiatives, legislation, health-service delivery and education. 32 The national smoking rate has declined from 22% in 2001 to 16% in 2014, 33 and from 49% in 2002 to 39% in 2014 in Indigenous population. 34 Continuing efforts are needed, however, to reduce the smoking rate in the remote Indigenous communities included in our study where the prevalence of smoking was high at 60% in Aboriginal and 45% in TSI adults.
In addition to the adverse impact of smoking on cancer risk reported in this population, [35] [36] [37] smoking accounts for 23% of the health gap between Indigenous and nonIndigenous Australians. 38 Smoking cessation is a high priority as a stronger adverse effect of smoking on Aboriginal people was reported in our study. The potential contribution of biological, cultural, environmental and lifestyle factors to this effect difference warrants further investigation. Strengths of our study include a broadly representative community-based sample of both Aboriginal and TSI adults from remote communities, use of objective clinical measurements wherever possible, and ascertainment of lifestyle factors at an individual level that could be retrieved from interviews. Limitations include a relatively short follow up period to detect cancer cases, a lack of detailed medical and family history, and some potential confounding factors (e.g., as relating to infections and diabetes duration and treatment). Indigenous people may be less likely to be recorded in hospital data from which cancer details in our study were retrieved, due to access barriers from financial, language and geographic factors.
14 In addition, some cancers were not included (e.g., skin cancers, which may be treated without hospital admissions and are not routinely recorded in cancer registries). Collectively these factors could have led to an underestimation of cancer incidence in the cohort. Misclassification of cancers may have also occurred due to inaccuracies in source hospital records. Finally, there were insufficient case numbers for cancer site-specific analysis (other than for coarse groupings) to study associations at a more precise level. The cancer groupings may have also been problematic since they were adapted from a clinical treatment classification rather than for research into aetiological risk factors.
In spite of these limitations, the 15-year follow-up of this Indigenous cohort from 26 rural and remote communities in North Queensland indicated: (a) a broadly equivalent allcancer incidence for this population to that for the Australian population overall; and (b) lung and liver cancer being the most common sites, which was similar to the profile reported for the national Indigenous population; (c) TSIs having a significantly higher all-cancer incidence than Aboriginal people for digestive cancers; (d) diabetes associated a higher risk of cancer overall, and liver and colorectal cancers and (e) smoking being a strong cancer risk factor as expected, more remarkable in Aboriginal adults.
Results indicate different cancer profiles in the two ethnic Indigenous groups from North Queensland, requiring different emphases in cancer prevention. For example, diabetes is especially common in TSIs whereas smoking in Aboriginal people. Attention is needed to address these modifiable risk factors in Aboriginal and TSI Australians.
